InDex Pharmaceuticals provides complementary information on

STOCKHOLM, Feb. 14, 2023 /PRNewswire/ -- InDex Pharmaceuticals Holding AB (publ) is today making a presentation with CEO Jenny Sundqvist available in light of the press release issued January

Related Keywords

Sweden , Stockholm , Swedish , Dennis Riedl , Johan Gil , Jenny Sundqvist , Prnewswire Index Pharmaceuticals Holding , Kindex Pharmaceuticals , Induction Study , Dex Pharmaceuticals , Immunomodulatory Sequences , Nasdaq First North Growth Market , Addex Pharma , Index , Pharmaceuticals , Rovides , Complementary , Information , Hase , Program , Conclude , Cobitolimod ,